Remdesivir in moderate to severe COVID-19: A matter of time?

被引：0
|
作者：
Bonazzetti, Cecilia [1 ,2 ]
Giacomelli, Andrea [1 ,2 ]
Pavia, Martina [2 ]
Fusetti, Chiara [1 ,2 ]
Gerbi, Martina [1 ,2 ]
Petri, Francesco [1 ,2 ]
Poloni, Andrea [1 ,2 ]
Oreni, Letizia [1 ]
Ridolfo, Anna Lisa [1 ]
Antinori, Spinello [1 ,2 ]
机构：
[1] Luigi Sacco Univ Hosp, Dept Infect Dis, ASST Fatebenefratelli Sacco, Milan, Italy
[2] Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Milan, Italy
来源：
PHARMACOLOGICAL RESEARCH | 2021年 / 170卷
关键词：
D O I：
10.1016/j.phrs.2021.105711
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Remdesivir treatment for patients with moderate to severe COVID-19
    Hasanoglu, Imran
    Guner, Rahmet
    Celik, Ilhami
    Kanat, Fikret
    Batirel, Ayse
    Dizman, Gulcin Telli
    Eren, Esma
    Sevgi, Dilek Yildiz
    Bozkurt, Ilkay
    Yasar, Kadriye Kart
    Senoglu, Sevtap
    Kazak, Esra
    Karaali, Ridvan
    Celikbas, Aysel
    Pullukcu, Husnu
    Cagatay, Arif Atahan
    Unal, Serhat
    Erdinc, Sebnem
    Tabak, Fehmi
    Gul, Ahmet
    Alp, Emine
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 880 - 887
  • [2] Is It Time to Revisit Remdesivir Use for Severe COVID-19?
    Taggarsi, Dipali Anand
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (09) : 983 - 984
  • [3] Remdesivir for patients with severe COVID-19
    Augustin, M.
    Hallek, M.
    Nitschmann, S.
    [J]. INTERNIST, 2020, 61 (06): : 644 - 645
  • [4] Remdesivir in Severe Cases of COVID-19 Infection
    Boretti, Alberto
    [J]. CURRENT ORGANOCATALYSIS, 2024, 11 (04) : 273 - 278
  • [5] Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis
    Mastroianni, Antonio
    Vangeli, Valeria
    Chidichimo, Luciana
    Urso, Filippo
    De Marco, Giuseppe
    Zanolini, Alfredo
    Greco, Francesca
    Mauro, Maria, V
    Greco, Sonia
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [6] No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials
    Hedskog, Charlotte
    Spinner, Christoph D.
    Protzer, Ulrike
    Hoffmann, Dieter
    Ko, Chunkyu
    Gottlieb, Robert L.
    Askar, Medhat
    Roestenberg, Meta
    de Vries, Jutte J. C.
    Carbo, Ellen C.
    Martin, Ross
    Li, Jiani
    Han, Dong
    Rodriguez, Lauren
    Parvangada, Aiyappa
    Perry, Jason K.
    Ferrer, Ricard
    Anton, Andres
    Andres, Cristina
    Casares, Vanessa
    Guenthard, Huldrych F.
    Huber, Michael
    Mccomsey, Grace A.
    Sadri, Navid
    Aberg, Judith A.
    van Bakel, Harm
    Porter, Danielle P.
    [J]. VIRUSES-BASEL, 2024, 16 (04):
  • [7] The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review
    Thiruchelvam, Kaeshaelya
    Kow, Chia Siang
    Hadi, Muhammad Abdul
    Hasan, Syed Shahzad
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (02) : 211 - 229
  • [8] Remdesivir, a remedy or a ripple in severe COVID-19?
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (11) : 1195 - 1198
  • [9] Clinical Outcomes of Remdesivir in Moderate and Severe Cases of COVID-19: A Retrospective Cohort Study
    Senthiappan, Ruth Priya
    Dambal, Archana A.
    Mohan, K.
    Aithal, Kiran R.
    Parakh, Rajendra Kumar
    Vuppumalla, Bhargav
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (01) : OC36 - OC38
  • [10] Remdesivir versus Standard of Care in Moderate to Severe COVID-19 Patients: A Retrospective Study
    Kumar, J. M. Jeetendra
    Vaibhav, S. B.
    Avinash, H. R.
    Pratheek, P.
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (04)
12345